Combined Haploidentical-Cord Blood Transplantation for Adults and Children
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Host Dendritic Cells in Allograft Patients
- Status
- UNKNOWN
- Phase
- PHASE1
Busulfan in Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Melphalan+Prednisolon With or Without Thalidomide in Previously Untreated Elderly Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
A Safety Confirmation Study on Lenalidomide With Dexamethasone In Japanese Patients With Previously Treated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Lenalidomide-Adriamycin-Dexamethasone (RAD) Induction Followed by Stem Cell Transplant in Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
PK Study of Melphalan HCL & Alkeran for Injection of MA Conditioning in MM Patients of Autologous Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.
- Status
- COMPLETED
- Phase
- N/A
Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Dose Escalation Study of the Combination of Lenalidomide (Revlimid®), Dexamethasone and Cyclophosphamide in Patients Refractory or Relapsing From Stable Disease With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Compare CNTO 328 (Anti-IL-6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone (VMP) With VMP Alone in Previously Untreated Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Non -Interventional Study-Palliative Therapy of Multiple Myeloma With a Combination of Lenalidomide and Dexamethasone
- Status
- COMPLETED
- Phase
- N/A
Study in Myeloma Patients Newly Diagnosed Treated as an Induction With Velcade-Dex or Velcade (Bortezomib) Thalidomide Dexamethasone (VTD)
- Status
- UNKNOWN
- Phase
- PHASE3
Serum Free Light Change in Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE1
Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VD
- Status
- COMPLETED
- Phase
- PHASE2
Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2